4 Common Causes Of Testosterone Deficiency In Men

If your hormone levels are lagging, consider these four common causes of low testosterone in men. Written By Meghan Belnap / Reviewed By Ray SpottsMore

4 Common Causes Of Testosterone Deficiency In Men
Written By Meghan Belnap / Reviewed By Ray Spotts
Testosterone deficiency is the silent epidemic that many men are too embarrassed to talk about. Low testosterone can cause unpleasant symptoms like fatigue, reduced libido, depression, weight gain and sleep disturbances. One in four men older than 30 suffers from less than optimal testosterone levels, but what causes a deficiency of this important hormone? The root of the problem varies from poor diet to medical conditions or just plain getting older. If your hormone levels are lagging, consider these four common causes of low testosterone in men.

Diet And Lifestyle

Carrying excess body fat, especially around your midsection, increases your body's estrogen levels and decreases testosterone. One of the best ways to combat low testosterone if you're overweight, sedentary or have a poor diet is to live a healthier lifestyle. Stop smoking, cut back on alcohol, maintain a healthy body mass index and exercise for at least half an hour each day.


The most common cause of low testosterone is also the one that's most difficult to fix. Testosterone levels begin to decline after age 30, and it's all downhill from there. Although there's no way to turn back the clock and increase your body's natural hormone production, testosterone replacement therapy offers an effective solution for declining testosterone levels with age. Bioidentical hormone replacement can help restore muscle mass, increase energy and balance your mood.


Underperforming or non-functioning testes in men is called hypogonadism. When the testes are not working properly, that means little or no testosterone is being produced. Hypogonadism can be caused by a problem with the testes themselves or the pituitary or hypothalamus gland. Some men are born with hypogonadism, while others develop this condition later in life. Treatment depends on the underlying cause, but typically involves replacing or supplementing testosterone with exogenous hormone.


The thyroid is a butterfly-shaped gland located in your neck, and thyroid hormone is required to make many of the body's hormones, including testosterone. Therefore, it makes sense that an underperforming thyroid leads to low testosterone. If you're diagnosed with low testosterone, the first thing you should do is have your thyroid tested. Supplementing with thyroid replacement hormone can help return your testosterone levels to normal.

Are you concerned about your testosterone levels? Don't be afraid to visit your healthcare provider and start the conversation. If you're uncomfortable discussing your low testosterone concerns with your regular doctor, consider visiting a specialist at a medical center that specializes in hormone replacement.

Subscribe to our newsletter for more information about , , . If you are looking for more health resources make sure to check out the  

Written By:
Meghan Belnap is a freelance writer who enjoys spending time with her family. She loves being in the outdoors and exploring new opportunities whenever they arise. Meghan finds happiness in researching new topics that help to expand her horizons. You can often find her buried in a good book or out looking for an adventure. You can connect with her on Facebook right  and Twitter right .

Reviewed By:

Founder Ray Spotts has a passion for all things natural and has made a life study of nature as it relates to health and well-being. Ray became a forerunner bringing products to market that are extraordinarily effective and free from potentially harmful chemicals and additives. For this reason Ray formed , a company you can trust for clean, effective, and healthy products. Ray is an organic gardener, likes fishing, hiking, and teaching and mentoring people to start new businesses. You can get his book for free, “How To Succeed In Business Based On God’s Word,” at .

Source : Trusted Health Products More   

What's Your Reaction?


Next Article

Report: Members of Russia’s ‘Business and Political Elite’ Have Been Receiving Experimental COVID-19 Vaccine

The vaccine completed a phase 1 trial last week involving military personnel, but study's results hasn’t been published

Report: Members of Russia’s ‘Business and Political Elite’ Have Been Receiving Experimental COVID-19 Vaccine

(Bloomberg) — Scores of Russia’s business and political elite have been given early access to an experimental vaccine against COVID-19, according to people familiar with the effort, as the country races to be among the first to develop an inoculation.

Top executives at companies including aluminum giant United Co. Rusal, as well as billionaire tycoons and government officials began getting shots developed by the state-run Gamaleya Institute in Moscow as early as April, the people said. They declined to be identified as the information isn’t public.

The Gamaleya vaccine, financed by the state-run Russian Direct Investment Fund and backed by the Defense Ministry, last week completed a phase 1 trial involving military personnel. The institute hasn’t published results for the study, which involved about 40 people, but has begun the next stage of testing with a larger group.

Gamaleya’s press office couldn’t be reached immediately for comment. Kremlin spokesman Dmitry Peskov, who recovered from COVID-19 after being hospitalized with the virus in May, said he doesn’t know the names of anyone who’s received the institute’s vaccine.

Asked on a conference call with reporters on Monday if President Vladimir Putin had taken it, Peskov said: “It probably wouldn’t be a good idea to use an uncertified vaccine on the head of state,” adding that he wasn’t aware of other officials trying it.

Peskov’s comments followed a Health Ministry statement that said only participants in Gamaleya’s trials are currently eligible for the jabs.

While the new shots are “safe” because they’re based on proven vaccines for other diseases, their effectiveness has yet to be determined, according to Sergei Netesov, a former executive at Vector, a state-run virology center in Novosibirsk, Siberia, that’s also working on an inoculation.

“Those who take it do so at their own risk,” Netesov said.

Russia has reported more than 750,000 cases of COVID-19, the fourth-largest total in the world, and Gamaleya’s program is on a faster track than many developers in the West. RDIF chief Kirill Dmitriev said last week phase 3 trials will start Aug. 3 and include thousands of people in Russia, Saudi Arabia and the United Arab Emirates, with the vaccine distributed nationally as early as September. Western researchers typically run phase 3 trials for months to better understand safety and effectiveness.

Gamaleya’s candidate is a so-called viral vector vaccine based on human adenovirus — a common cold virus — fused with the spike protein of SARS CoV-2 to stimulate an immune response. It is similar to a vaccine being developed by China’s CanSino Biologics, which is already in phase 2 trials with plans for more in Canada.

Canada was among the countries — along with the U.S. and U.K. — that last week accused Russian government-backed hackers of trying to steal secrets of their vaccine research. Russian officials deny the allegations.

The program under which well-connected Russians have been given the chance to volunteer for doses of the experimental vaccine is legal but kept under wraps to avoid a crush of potential participants, according to a researcher familiar with the effort. He said several hundred people have been involved. Bloomberg confirmed dozens who have had the shots but none would allow their names to be published.

It’s not clear how participants are selected and they aren’t part of the official studies, though they are monitored and their results logged by the institute.

Dmitriev of the RDIF said he and his family had taken the shots and noted that a significant number of other volunteers have also been given the opportunity. He declined to provide further details. The Gamaleya Institute said it vaccinated its director, as well as the team working on the trial, when it started. In May, state-controlled Sberbank recruited volunteers among employees to take the jabs.

One senior executive who’s been inoculated said he experienced no side effects. He said the health risks are worth being able to resume normal life, both personal and professional. Other takers reported experiencing fevers and muscle aches after getting the shots.

Several managers in the Moscow offices of Rusal, which relies on Gamaleya’s Ebola vaccine to maintain operations in the West African country of Guinea, have already taken the institute’s COVID-19 shots, people familiar with the matter said. Fertilizer maker PhosAgro PJSC is among the corporations who’ve been invited to follow suit, other people said. Spokespeople for Rusal and Phosagro declined to comment.

Some executives at major companies said they turned down the offer on health concerns. One tycoon said he decided against participating after his doctor told him it would take at least a year to assess the new vaccine’s risks.

Initial results from CanSino’s trial showed its adenovirus-based vaccine had a diminished effect in some people who had a pre-existing immunity to that pathogen. RDIF’s Dmitriev said researchers in Russia are testing two different types of adenovirus vectors in order to reduce the chances of pre-existing immunity reducing the cocktail’s effectiveness.

Gamaleya chief Alexander Ginzbur said he wasn’t aware of any government officials or business leaders taking his institute’s vaccine, according to Interfax.

—With assistance from Irina Reznik and Andrey Biryukov.

Source : Time More   

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.